Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 28/5/2021 đến ngày 04/6/2021. 


1. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response                            

International Journal of Infectious Diseases, 15 March 2021, Volume 105, Pages 756-762

Seniha Başaran, Serap Şimşek-Yavuz, Haluk Eraksoy


2. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19

Patterns, 5 April 2021, Volume 2, Issue 5, Article 100247

Sudhir Ghandikota, Mihika Sharma, Anil G. Jegga


3. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms

Gastroenterology, 4 March 2021, Volume 160, Issue 7, Pages 2435-2450.e34

Alexandra E. Livanos, Divya Jha, Saurabh Mehandru


4. Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists

European Journal of Medicinal Chemistry, 20 March 2021, Volume 218, Article 113390

Sheng Zhang, Maj Krumberger, James S. Nowick


5. Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories

Clinical Microbiology Newsletter, 21 May 2021, Volume 43, Issue 11, Pages 89-96

Blake W. Buchan, Joseph D. Yao


6. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

European Journal of Cancer, 1 April 2021, Volume 150, Pages 232-239

David Tougeron, Maxime Hentzien, Olivier Bouché


7. Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study

Clinical Epidemiology and Global Health, 19 April 2021, Volume 11, Article 100747

Asako Doi, Kentaro Iwata, Yasuki Kihara


8. Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests

Journal of Infection and Chemotherapy, 15 March 2021, Volume 27, Issue 7, Pages 1033-1038

Nobuyuki Ashizawa, Takahiro Takazono, Hiroshi Mukae


9. Computational insights of phytochemical-driven disruption of RNA-dependent RNA polymerase-mediated replication of coronavirus: a strategic treatment plan against coronavirus disease 2019

New Microbes and New Infections, 31 March 2021, Volume 41, Article 100878

A. Balkrishna, R. Mittal, V. Arya


10. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) coinfection: A unique case series

Travel Medicine and Infectious Disease, 13 March 2021, Volume 41, Article 102026

Alyaa Elhazmi, Jaffar A. Al-Tawfiq, Abbas Al Mutair


11. Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations

Biophysical Chemistry, 29 April 2021, Volume 275, Article 106608

Divya Shaji, Shohei Yamamoto, Noriyuki Kurita


12. Enhanced throughput of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time RT-PCR panel by assay multiplexing and specimen pooling

Journal of Virological Methods, 8 April 2021, Volume 293, Article 114149

Xiaoyan Lu, Senthilkumar K. Sakthivel, Sheila M. Dollard


13. Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

Journal of Clinical Virology, 24 April 2021, Volume 139, Article 104847

Martin Dugas, Tanja Grote-Westrick, Joachim Kühn


14. ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors

Clinica Chimica Acta, 3 May 2021, Volume 519, Pages 206-209

Jaroslav A. Hubacek, Ladislav Dusek, Vera Adamkova


15. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019

Journal of Ethnopharmacology, 5 April 2021, Volume 275, Article 114098

Huaying Wu, Ke Gong, Mengzhou Xie


16. The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors

Clinical Epidemiology and Global Health, 10 May 2021, Volume 11, Article 100763

Shinta Oktya Wardhani, Jonny Karunia Fajar, Harapan Harapan


17. Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre-Sars-CoV-2 environment

Diagnostic Microbiology and Infectious Disease, 17 February 2021, Volume 100, Issue 2 (Cover date: June 2021), Article 115352

Justin Hardick, Kathryn Shaw-Saliba, Richard E. Rothman



1. Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities

Shireen Nigar, SM Tanjil Shah, Md. Ali Ahasan Setu, Sourav Dutta Dip, Habiba Ibnat, M Touhidul Islam, Selina Akter, Iqbal Kabir Jahid, M Anwar Hossain

Journal of Medical Virology

First published: 01 June 2021


2. Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods

Petra Emmerich, Ronald von Possel, Christoph Josef Hemmer, Carlos Fritzsche, Hilte Geerdes-Fenge, Babett Menge, Claudia Messing, Viola Borchardt-Lohölter, Christina Deschermeier, Katja Steinhagen

Journal of Medical Virology

First published: 01 June 2021


3. Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca2+-dependent membrane fusion

Yang Yang, Peng Yang, Cong Huang, Yuming Wu, Zhe Zhou, Xuejun Wang, Shengqi Wang

Journal of Medical Virology

First published: 01 June 2021


4. Human CD4+ T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential

Johan Verhagen, Edith D. van der Meijden, Vanessa Lang, Andreas E. Kremer, Simon Völkl, Andreas Mackensen, Michael Aigner, Anita N. Kremer

Clinical & Experimental Immunology

First published: 01 June 2021


5. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study

Daniele Noviello, Andrea Costantino, Antonio Muscatello, Alessandra Bandera, Dario Consonni, Maurizio Vecchi, Guido Basilisco

Neurogastroenterology & Motility

First published: 01 June 2021



1. Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post‐translational modification: a multiple target approach

Rajveer Singh, Anupam Gautam, Shivani Chandel, Vipul Sharma… in In Silico Pharmacology (2021)


2. Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial

H. Rahimi, A. Allahyari, S. Ataei Azimi, M. Kamandi, Z. Mozaheb, F. Zemorshidi… in Trials (2021)


3. Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice

Tong Gao, Yi Ren, Shuangqin Li, Xin Lu, Han Lei in Microbial Cell Factories (2021


4. Cerebral Venous Thrombosis in Acute Lymphoblastic Leukemia with Severe COVID-19: a Case Report

Ishita Manral, Nihar Duddu, Neelabh Nayan… in SN Comprehensive Clinical Medicine (2021)


5. Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections

Enas Fakhry Abdel-Hamed, Mohamed N. Ibrahim, Nahed E. Mostafa… in Gut Pathogens (2021)


6. The evolution of chest CT findings from admission to follow-up in 30 moderate to severe adult patients with COVID-19 pneumonia

Yunfeng Zhou, Hao Ren, Shuo Wang, Feng You… in Chinese Journal of Academic Radiology (2021)


7. Clinical and laboratory findings in COVID-19 adult hospitalized patients from Alborz province / Iran: comparison of rRT-PCR positive and negative

Farnaz Karimi, Amir Abbas Vaezi, Mostafa Qorbani… in BMC Infectious Diseases (2021)


8. Infectivity of deceased COVID-19 patients

Stefanie Plenzig, D. Bojkova, H. Held, A. Berger… in International Journal of Legal Medicine (2021)


9. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study

Luigi Angelo Vaira, Andrea De Vito… in European Archives of Oto-Rhino-Laryngology (2021)


10. Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

Johannes G. M. Koeleman, Henk Brand… in European Journal of Clinical Microbiology … (2021)